Background Patents. UW Ref. No. Serial Number Filing Type Filing Date Notes [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] [* * *] THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. [* * *] [* * *] [* * *] [* * *]
Background Patents. The Parties have not identified any LICENSOR Background Patents that the parties believe are necessary for LICENSEE to make or use the Licensed Products. In the event that the Parties discover LICENSOR Background Patents that are necessary for LICENSEE to make or use the Licensed Products, the Parties agree to negotiate in good faith, upon request by either party, for a license to the LICENSOR Background Patents, (“Additional Patents”). The license to any Additional Patents shall be made subject to and limited by all previous and then existing encumbrances, grants and extensions thereof, and all other obligations to third parties with respect to the Additional Patents. Nothing set forth in this section 2.07 shall be deemed to restrict in any way either party from entering into agreement with other third parties relating to any Background Intellectual Property including the Additional Patents. Thus it is possible that LICENSOR’s right to license the Additional Patents may be limited by existing agreements and may be further limited or extinguished by possible future agreements with other third parties, which may include, but is not limited to assignment of these Additional Patents to third parties.
Background Patents. Ventana shall have the right, but no obligation, to prosecute and maintain, and to control, enforce, and defend worldwide, at its own expense, Ventana Background Intellectual Property. Blueprint shall have the right, but no obligation, to prosecute and maintain, and to control, enforce, and defend worldwide, at its own expense, Blueprint Background Intellectual Property.
Background Patents. Transcrypt and Transcrypt affiliates agree not to assert any rights under any patent, copyright, trademark or any claim of trade secret generated as a result of co-developed products, which will or might inhibit, Private-Label/Supplier Agreement Analog Scrambling Modules prevent, or otherwise interfere with Motorola's ability to make, use, or sell, or have made, or have sold, or cause to be sold, the co-developed products.
Background Patents. Each Party will be responsible for the preparation, filing, prosecution, maintenance, defense and extension of Patent Rights claiming Improvements to such Party’s Background Technology and any other Inventions made solely by or on behalf of a Party that are not otherwise included in the Joint Collaboration Technology.
Background Patents. 9.1. UMM shall notify EXIGENT of its background patents or patent applications, those of its affiliates and any patents or applications of others of which UMM is aware or becomes aware which are to be used in the Development Services or supply services described in Article 3.0.
Background Patents. Company shall have the sole right, but not the obligation, at its expense, to control the Prosecution and Maintenance of the Company Background Patents and Amgen shall have the sole right, but not the obligation, at its expense, to control the Prosecution and Maintenance of the Amgen Background Patents.
Background Patents. As between the Parties, for any Background Patents, the Party that owns (or has in-licensed such Patent from a Third Party) the applicable Background Patent, shall control the preparation, filing, prosecution and maintenance of such Background Patent, using counsel of its choice, and at AzurRx’s sole expense, provided that such prosecution and maintenance expenses shall be shared between the Parties if the given patent or patent application is relevant to both Parties’ development programs. A Party shall keep the other Party reasonably informed of all material steps with regard to the preparation, filing, prosecution, and maintenance of such Background Patents, and shall provide the other Party with a copy of material communications to and from the patent authorities regarding such Background Patents, including drafts of any material filings or responses to be made to such patent authorities sufficiently in advance of submitting such filings or responses so as to allow the other Party a reasonable opportunity to review and comment thereon. The Party shall reasonably consider, but shall have no obligation, to incorporate the other Party’s requests and suggestions with respect to such drafts and with respect to strategies for filing and prosecuting such Background patents. Except as set forth in this Section 9.2.1, if a Party, during the Term, determines in its sole discretion to abandon or not maintain a given patent or patent application within such Background Patents, then the Party shall provide the other Party with prior written notice sufficiently in advance of any abandonment to enable the other Party, at its sole discretion, to maintain such Background Patents and assume the prosecution in the joint names of the Parties, at its sole cost and expense, and on receipt of such notice, the Party shall transfer such prosecution to the other Party.
Background Patents. (l) The Contractor agrees:
Background Patents. For the avoidance of doubt, as between the Parties, (a) Regeneron has the sole right, but not the obligation, to prepare, file, prosecute and maintain, and defend against interference, opposition, post-grant review, reissue or reexamination proceedings in respect of, the Regeneron Background Patents at its cost and expense and (b) Sanofi has the sole right, but not the obligation, to prepare, file, prosecute and maintain, and defend against interference, opposition, post-grant review, reissue or reexamination proceedings in respect of, the Sanofi Background Patents at its cost and expense.
